Home - Products - Others - Other Targets - Caerulein, desulfated TFA (20994-83-6 free base)

Caerulein, desulfated TFA (20994-83-6 free base)

CAS No. ——

Caerulein, desulfated TFA (20994-83-6 free base)( —— )

Catalog No. M30076 CAS No. ——

Caerulein, desulfated TFA is Caerulein after desulfurization.Caerulein is a deceptide with the same five carboxy-terminating amino acids as gastrin and cholecystatin (CCK).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Caerulein, desulfated TFA (20994-83-6 free base)
  • Note
    Research use only, not for human use.
  • Brief Description
    Caerulein, desulfated TFA is Caerulein after desulfurization.Caerulein is a deceptide with the same five carboxy-terminating amino acids as gastrin and cholecystatin (CCK).
  • Description
    Caerulein, desulfated TFA is Caerulein after desulfurization.Caerulein is a deceptide with the same five carboxy-terminating amino acids as gastrin and cholecystatin (CCK)..
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    1386.36
  • Molecular Formula
    C60H74F3N13O20S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    Sequence:{Glp}{Gln}{Asp}{Tyr}{Thr}{Gly}{Trp}{Met}{Asp}{Phe}-NH2

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Johnson LR, et al. Effect of sulfation on the gastrointestinal actions of caerulein. Gastroenterology. 1970 Feb;58(2):208-16.
molnova catalog
related products
  • 3,5-Dihydroxy-4,6,7-...

    Eupatorin analog. Reference standards.

  • Borapetoside E

    Borapetoside E has anti-hyperglycemic activity, it can significantly reduce serum glucose levels at dose-dependent manners in alloxan-induced hyperglycemic mice and db/db type 2 diabetic mice.

  • BRM/BRG1 ATP Inhibit...

    BRM/BRG1 ATP Inhibitor-1 is an allosteric dual Brahma homolog (BRM)/SWI/SNF related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 (SMARCA2) and BRG1/SMARCA4 ATPase activity inhibitor (IC50s<0.005 μM).